Cannara Biotech Inc. (LOVFF)
OTCMKTS · Delayed Price · Currency is USD
1.258
+0.018 (1.45%)
At close: Sep 17, 2025
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of $116.31 million as of September 18, 2025. Its market cap has increased by 160.51% in one year.
Market Cap
116.31M
Enterprise Value
140.34M
Revenue
74.05M
Ranking
n/a
PE Ratio
10.31
Stock Price
$1.26
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 159.42M to 116.31M, a decrease of -27.04%. That is a compound annual growth rate of -4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 116.31M | 151.22% |
| Dec 31, 2024 | 46.30M | -18.17% |
| Dec 29, 2023 | 56.58M | -8.15% |
| Dec 30, 2022 | 61.59M | -34.13% |
| Dec 31, 2021 | 93.50M | 101.84% |
| Dec 31, 2020 | 46.32M | -31.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |